Iwasaka T - Search Results

1

Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes.

Kosaki A, Hasegawa T, Kimura T, Iida K, Hitomi J, Matsubara H, Mori Y, Okigaki M, Toyoda N, Masaki H, Inoue-Shibata M, Nishikawa M, Iwasaka T. Kosaki A, et al. Among authors: iwasaka t. J Clin Endocrinol Metab. 2004 Nov;89(11):5423-8. doi: 10.1210/jc.2003-032223. J Clin Endocrinol Metab. 2004. PMID: 15531492

2

The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages.

Hasegawa T, Kosaki A, Kimura T, Matsubara H, Mori Y, Okigaki M, Masaki H, Toyoda N, Inoue-Shibata M, Kimura Y, Nishikawa M, Iwasaka T. Hasegawa T, et al. Among authors: iwasaka t. Atherosclerosis. 2003 Dec;171(2):211-8. doi: 10.1016/j.atherosclerosis.2003.08.021. Atherosclerosis. 2003. PMID: 14644389

3

Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis.

Mori Y, Kosaki A, Kishimoto N, Kimura T, Iida K, Fukui M, Nakajima F, Nagahara M, Urakami M, Iwasaka T, Matsubara H. Mori Y, et al. Among authors: iwasaka t. Am J Nephrol. 2009;29(1):18-24. doi: 10.1159/000148646. Epub 2008 Jul 26. Am J Nephrol. 2009. PMID: 18663285

4

Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells.

Maeda A, Toyoda N, Yasuzawa-Amano S, Iwasaka T, Nishikawa M. Maeda A, et al. Among authors: iwasaka t. Mol Cell Endocrinol. 2003 Feb 28;200(1-2):111-7. doi: 10.1016/s0303-7207(02)00409-4. Mol Cell Endocrinol. 2003. PMID: 12644304

5

Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.

Amano K, Okigaki M, Adachi Y, Fujiyama S, Mori Y, Kosaki A, Iwasaka T, Matsubara H. Amano K, et al. Among authors: iwasaka t. J Mol Cell Cardiol. 2004 Apr;36(4):469-80. doi: 10.1016/j.yjmcc.2004.01.006. J Mol Cell Cardiol. 2004. PMID: 15081307

6

Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media.

Yasuzawa-Amano S, Toyoda N, Maeda A, Kosaki A, Mori Y, Iwasaka T, Nishikawa M. Yasuzawa-Amano S, et al. Among authors: iwasaka t. Endocrinology. 2004 Dec;145(12):5638-45. doi: 10.1210/en.2004-0632. Epub 2004 Sep 2. Endocrinology. 2004. PMID: 15345674

7

Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.

Hasegawa T, Kosaki A, Shimizu K, Matsubara H, Mori Y, Masaki H, Toyoda N, Inoue-Shibata M, Nishikawa M, Iwasaka T. Hasegawa T, et al. Among authors: iwasaka t. Exp Neurol. 2006 Jun;199(2):274-80. doi: 10.1016/j.expneurol.2005.11.001. Epub 2005 Dec 6. Exp Neurol. 2006. PMID: 16337192

8

Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients.

Takahashi N, Morimoto S, Okigaki M, Seo M, Someya K, Morita T, Matsubara H, Sugiura T, Iwasaka T. Takahashi N, et al. Among authors: iwasaka t. Nephrol Dial Transplant. 2011 Apr;26(4):1252-7. doi: 10.1093/ndt/gfq547. Epub 2010 Sep 3. Nephrol Dial Transplant. 2011. PMID: 20817670

9

Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease.

Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T. Shibasaki Y, et al. Among authors: iwasaka t. Nephron. 2002 Mar;90(3):256-61. doi: 10.1159/000049060. Nephron. 2002. PMID: 11867945 Clinical Trial.

10

Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.

Uchiyama-Tanaka Y, Matsubara H, Mori Y, Kosaki A, Kishimoto N, Amano K, Higashiyama S, Iwasaka T. Uchiyama-Tanaka Y, et al. Among authors: iwasaka t. Kidney Int. 2002 Sep;62(3):799-808. doi: 10.1046/j.1523-1755.2002.00537.x. Kidney Int. 2002. PMID: 12164862 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page